Immediate release fixed dose combination product [Regulatives / Guidelines]

posted by ping4santosh  – India, 2020-03-11 13:22 (1062 d 17:18 ago) – Posting: # 21243
Views: 3,991

Dear Ohlbe,

Awaiting your thoughtful response!

Best wishes,
SKM


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5! You even included the link to the post explaining why TOFU is strongly discouraged in the Forum. BTW, you replied to yourself and not to Ohlbe. Relax; see also this post #9.
This is the first warning. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,481 posts in 4,710 threads, 1,603 registered users;
17 visitors (0 registered, 17 guests [including 8 identified bots]).
Forum time: 06:41 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5